lutetium (177Lu) oxodotreotide · Medicine question

Have myelodysplastic syndrome and acute leukaemia been reported after treatment with Lutathera (lutetium (177Lu) oxodotreotide)?

Name: Have myelodysplastic syndrome and acute leukaemia been reported after treatment with Lutathera (lutetium (177Lu) oxodotreotide)?
Published: 2026-11-08T01:56:56.259Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Late-onset myelodysplastic syndrome and acute leukaemia have been observed after treatment with Lutathera (lutetium (177Lu) oxodotreotide).

Sources for this answer

Lutathera 370 MBq/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated 8 April 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about lutetium (177Lu) oxodotreotide